Madison Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.36M | Sell |
6,401
-19
| -0.3% | -$9.98K | 0.04% | 197 |
|
|
2025
Q1 | $4.07M | Sell |
6,420
-25
| -0.4% | -$15.9K | 0.05% | 178 |
|
|
2024
Q4 | $4.59M | Sell |
6,445
-114
| -2% | -$81.2K | 0.05% | 173 |
|
|
2024
Q3 | $6.9M | Sell |
6,559
-1,069
| -14% | -$1.12M | 0.08% | 153 |
|
|
2024
Q2 | $8.02M | Sell |
7,628
-163
| -2% | -$171K | 0.1% | 142 |
|
|
2024
Q1 | $7.5M | Sell |
7,791
-499
| -6% | -$480K | 0.09% | 149 |
|
|
2023
Q4 | $7.28M | Sell |
8,290
-103
| -1% | -$90.5K | 0.1% | 149 |
|
|
2023
Q3 | $6.91M | Sell |
8,393
-134
| -2% | -$110K | 0.1% | 150 |
|
|
2023
Q2 | $6.13M | Sell |
8,527
-31
| -0.4% | -$22.3K | 0.09% | 151 |
|
|
2023
Q1 | $7.03M | Sell |
8,558
-51
| -0.6% | -$41.9K | 0.11% | 145 |
|
|
2022
Q4 | $6.21M | Sell |
8,609
-91
| -1% | -$65.7K | 0.1% | 149 |
|
|
2022
Q3 | $5.99M | Sell |
8,700
-18
| -0.2% | -$12.4K | 0.1% | 142 |
|
|
2022
Q2 | $5.15M | Buy |
+8,718
| New | +$5.15M | 0.08% | 161 |
|